Earnings Per Share

9 Months Ended

Sep. 30, 2021

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

Note 12 – Earnings Per Share

The following table summarizes earnings per share calculations for the three and nine months ended September 30, 2021 and

2020:

Three Months Ended 

Nine Months Ended

September 30,

September 30,

2021

2020

2021

2020

Basic earnings (loss) per common share

Net income (loss) attributable to Quaker Chemical Corporation

$

31,058

$

27,304

$

103,243

$

(8,812)

Less: (income) loss allocated to participating securities

(119)

(113)

(413)

44

Net income (loss) available to common shareholders

$

30,939

$

27,191

$

102,830

$

(8,768)

Basic weighted average common shares outstanding

17,812,216

17,743,538

17,800,082

17,704,662

Basic earnings (loss) per common share

$

1.74

$

1.53

$

5.78

$

(0.50)

Diluted earnings (loss) per common share

Net income (loss) attributable to Quaker Chemical Corporation

$

31,058

$

27,304

$

103,243

$

(8,812)

Less: (income) loss allocated to participating securities

(119)

(113)

(412)

44

Net income (loss) available to common shareholders

$

30,939

$

27,191

$

102,831

$

(8,768)

Basic weighted average common shares outstanding

17,812,216

17,743,538

17,800,082

17,704,662

Effect of dilutive securities

58,176

57,327

59,986

—

Diluted weighted average common shares outstanding

17,870,392

17,800,865

17,860,068

17,704,662

Diluted earnings (loss) per common share

$

1.73

$

1.53

$

5.76

$

(0.50)

Certain stock options and restricted stock units are not included in the diluted earnings (loss) per share calculation when the effect

would have been anti-dilutive. The calculated amount of anti-diluted shares not included was

5,531

 and

3,722

 for the three and nine

months ended September 30, 2021, respectively. All of the Company’s potentially dilutive shares for the nine months ended

September 30, 2020 are anti-dilutive and not included in the dilutive loss per share calculations because of the Company’s net loss

during the period. There were

no

 anti-dilutive shares excluded from the diluted earnings per share calculation for the three months

ended September 30, 2020.